Table 2.
Information on patient-derived tampons including primary cancer, clinical diagnoses, and initial slopes and estimated concentration based on FLOWER
| ID | Primary cancer | Diagnosis | Patient age | Menopause status | Initial slope (fm/s) | Estimated concentration (pM) |
|---|---|---|---|---|---|---|
| TP10 | Benign | Endosalpinogiosis | 46 | Postmenopausal | −6.267 | 0.571 |
| TP48 | Benign | Leiomyoma | 63 | Postmenopausal | 12.860 | 713.894 |
| TP50 | Benign | Endosalpingiosis | 38 | Premenopausal | 5.318 | 42.913 |
| TP24 | Ovarian | Clear cell carcinoma | 65 | Postmenopausal | 10.510 | 297.282 |
| TP34 | Ovarian | Low-grade serous carcinoma | 33 | Premenopausal | 11.432 | 358.195 |
| TP42 | Ovarian | Carcinosarcoma | 59 | Postmenopausal | 2.426 | 14.606 |